2023
DOI: 10.1021/acs.oprd.3c00032
|View full text |Cite
|
Sign up to set email alerts
|

Development of Versatile Routes for the Preparation of an Intermediate to Immuno-Oncology Agonist BMS-986299

Abstract: The development and optimization of two efficient and convenient routes for the construction of synthetic equivalents of 2-chloro-5-(1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl)aniline, a key intermediate to immuno-oncology agonist (BMS-986299), is described. The developed routes started from commercial available reagents into the desired pyrazole scaffolds smoothly with different substituents such as THP-, Bn-, and PMB-group tolerance. Finally, to further demonstrate the practicability, a large-scale process… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 40 publications
0
0
0
Order By: Relevance